IXICO says that results for the year to September 2019 will be better than expected.
The neuroscience-focused data analytics company is accelerating its revenue growth thanks to expanded contracts. The business is operationally geared so this has boosted profitability.
The share price rose by two-thirds to 57p.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.